Protein Technologies, Inc., a Tucson, Arizona-based provider of peptide synthesis instruments, received an equity investment and a credit facility of undisclosed amount.
Ampersand Capital Partners made the investment while Square 1 Bank provided the debt financing.
The company intends to use the funds to expand operations.
Founded in 1985 and led by Nate Cosper, president and chief executive officer, Protein Technologies designs, manufactures and supplies peptide synthesizers and reagents to academic and commercial researchers at universities, biotechnology and pharmaceutical companies.
FinSMEs
30/07/2015